MyHealthChecked PLC (AIM:MHC, FRA:0I1)'s (AIM:MHC) Penny McCormick talks to Proactive London's Katie Pilbeam about their business model, their growth strategy and latest set of results.
The firm just reported their half year results for the six months which ended 30th June 2021, 'a period of considerable growth driven by a dramatic ramp-up in COVID-19 PCR testing service revenues'.
Commercial highlights include signing two agreements with Boots UK Limited to supply their COVID-19 PCR test kits and associated laboratory services. As well as signing a commercial agreement with AAH Pharmaceuticals Limited (Lloyds Pharmacy).
The AIM-listed firm offers a range of accessible testing options from private COVID testing through to insight into intolerances and genetic predispositions, they 'promise clarity, accuracy and an affordable service you can trust'.